Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of depressive symptoms and their treatment on completing antiviral treatment in patients with chronic hepatitis C.

Journal of clinical gastroenterology - 1 Sept 2010

Liu Stanley S, Schneekloth Terry D, Talwalkar Jayant A, Kim W Ray, Poterucha John J, Charlton Michael R, Wiesner Russell H, Gross John B

Abstract excerpt

BACKGROUND/GOALS: Interferon-induced depression affects 20% to 40% of patients treated for chronic hepatitis C virus (HCV). The aim of our study was to examine the influence of antidepressant treatment and whether this improves the likelihood of completing therapy. METHODS: One hundred randomly selected patients with chronic HCV undergoing antiviral therapy at a single center were identified. Patients were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Antiviral Agents

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Depressive Disorder

Share to Hepacivirus

Share to Hepatitis C, Chronic

Share to Medication Adherence

Share to Time Factors

Share to Treatment Outcome

Source

Identifiers

PMID: 20495464
DOI: 10.1097/MCG.0b013e3181dc250f

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of depressive symptoms and their treatment on completing antiviral treatment in patients with chronic hepatitis C.PMID 20495464Read ↗

The Severity of Depressive Symptoms as an Independent Predictor of Sustained Virological Response During Treatment of Hepatitis C With Pegylated Interferon-α2a and Oral Ribavirin.Semantic proximity Read ↗

Sustained virological response in the antiviral therapy of chronic hepatitis C: is there a predictive value of interferon-induced depression?Semantic proximity Read ↗

Genotype 1 of hepatitis C virus increases the risk of major depression: a 12-week prospective study.Semantic proximity Read ↗

PS2-10: Predictors of Depression and Poor Physical Health among Patients with Chronic Hepatitis C Infection: Results from the Chronic Hepatitis Cohort StudySemantic proximity Read ↗

Factors associated with treatment failure of patients with psychiatric diseases and injecting drug users in the treatment of genotype 2 or 3 hepatitis C chronic infection.Semantic proximity Read ↗

[Increased prevalence of depression in hepatitis C infection patients].Semantic proximity Read ↗

Biological mechanisms of depression following treatment with interferon for chronic hepatitis C: A critical systematic review.Semantic proximity Read ↗

Utilizing genomic polymorphisms to personalize hepatitis C therapies.Semantic proximity Read ↗

A functional serotonin transporter gene polymorphism and depressive effects associated with interferon-alpha treatment.Semantic proximity Read ↗

Depression is not associated with peripheral insulin resistance in patients with chronic hepatitis C infection.Semantic proximity Read ↗

Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C.Semantic proximity Read ↗

Serotonin gene polymorphisms and lifetime mood disorders in predicting interferon-induced depression in chronic hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.